You are searching for: hsa04912

---

T48598 Target Info	Target Name	GTPase KRas (KRAS)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	AZD4785	Drug Info

T32348 Target Info	Target Name	Early growth response protein 1 (EGR-1)
	Target type	Clinical trial Target
	Disease	Pain;
	Drugs	AYX-1	Drug Info

T10383 Target Info	Target Name	Phospholipase D2 (PLD2)
	Target type	Clinical trial Target
	Disease	Coagulation defect;
	Drugs	VU0364739	Drug Info

T03046 Target Info	Target Name	Mutated KRAS (mKRAS)
	Target type	Clinical trial Target
	Disease	Pancreatic cancer;
	Drugs	GI-4000 + gemcitabine	Drug Info

T00663 Target Info	Target Name	Stress-activated protein kinase JNK3 (JNK3)
	Target type	Patented-recorded Target
	Disease	Central nervous system injury;
	Drugs	7-azaindole derivative 6	Drug Info

T69375 Target Info	Target Name	Stress-activated protein kinase JNK2 (JNK2)
	Target type	Preclinical Target
	Disease	T-cell leukaemia;
	Drugs	PMID25991433-Compound-D2	Drug Info

T16538 Target Info	Target Name	EGFR T790M mutant (EGFR T790M)
	Target type	Successful Target
	Disease	Non-small-cell lung cancer; Melanoma;
	Drugs	Osimertinib	Drug Info

T70851 Target Info	Target Name	Extracellular signal-regulated kinase 5 (ERK5)
	Target type	Patented-recorded Target
	Disease	Not Available
	Drugs	PMID26924192-Compound-30	Drug Info

T69085 Target Info	Target Name	Transcription factor AP-1 (JUN)
	Target type	Discontinued Target
	Disease	Rheumatoid arthritis;
	Drugs	T-5224	Drug Info

T38996 Target Info	Target Name	Phospholipase D1 (PLD1)
	Target type	Patented-recorded Target
	Disease	Not Available
	Drugs	US9127005, P2C	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.